Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA
- Thursday, October 15, 2020, 7:02
- Finance
- Add a comment
SEATTLE, Oct. 15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s…
About the Author
adminasapcorp has written 42188 stories on this site.